Pharma & Healthcare

Global Frozen Shoulder Treatment Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Frozen Shoulder Treatment Drugs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Yunnan Baiyao
Renhe Pharmacy
Sunflower Pharmaceutical
DR.ROTUS
Tongrentang
Jiugang Pharmaceutical
Hisamitsu
Kobayashi Pharmaceutical
Haishi Hainuo Group
North China Pharmaceutical
Qizheng Tibetan Medicine
Baiyunshan Pharmaceutical
Hengjian Pharmaceutical
Segment by Type
External Use
Oral
Segment by Application
Hospital Clinic
Pharmacy
Online Shopping Mall
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Frozen Shoulder Treatment Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Frozen Shoulder Treatment Drugs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Frozen Shoulder Treatment Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 External Use
1.2.3 Oral
1.3 Market Segmentation by Application
1.3.1 Global Frozen Shoulder Treatment Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Online Shopping Mall
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Frozen Shoulder Treatment Drugs Revenue Estimates and Forecasts 2020-2031
2.2 Global Frozen Shoulder Treatment Drugs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Frozen Shoulder Treatment Drugs Sales Estimates and Forecasts 2020-2031
2.4 Global Frozen Shoulder Treatment Drugs Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Frozen Shoulder Treatment Drugs Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Frozen Shoulder Treatment Drugs Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 External Use Market Size by Manufacturers
3.5.2 Oral Market Size by Manufacturers
3.6 Global Frozen Shoulder Treatment Drugs Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Frozen Shoulder Treatment Drugs Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Frozen Shoulder Treatment Drugs Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Frozen Shoulder Treatment Drugs Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Frozen Shoulder Treatment Drugs Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Frozen Shoulder Treatment Drugs Sales and Revenue by Type (2020-2031)
6.4 North America Frozen Shoulder Treatment Drugs Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Frozen Shoulder Treatment Drugs Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Frozen Shoulder Treatment Drugs Sales and Revenue by Type (2020-2031)
7.4 Europe Frozen Shoulder Treatment Drugs Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Frozen Shoulder Treatment Drugs Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Frozen Shoulder Treatment Drugs Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Frozen Shoulder Treatment Drugs Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Frozen Shoulder Treatment Drugs Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Frozen Shoulder Treatment Drugs Sales and Revenue by Type (2020-2031)
9.4 Central and South America Frozen Shoulder Treatment Drugs Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Frozen Shoulder Treatment Drugs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Frozen Shoulder Treatment Drugs Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Frozen Shoulder Treatment Drugs Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Frozen Shoulder Treatment Drugs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Yunnan Baiyao
11.1.1 Yunnan Baiyao Corporation Information
11.1.2 Yunnan Baiyao Business Overview
11.1.3 Yunnan Baiyao Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.1.4 Yunnan Baiyao Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Yunnan Baiyao Frozen Shoulder Treatment Drugs Sales by Product in 2024
11.1.6 Yunnan Baiyao Frozen Shoulder Treatment Drugs Sales by Application in 2024
11.1.7 Yunnan Baiyao Frozen Shoulder Treatment Drugs Sales by Geographic Area in 2024
11.1.8 Yunnan Baiyao Frozen Shoulder Treatment Drugs SWOT Analysis
11.1.9 Yunnan Baiyao Recent Developments
11.2 Renhe Pharmacy
11.2.1 Renhe Pharmacy Corporation Information
11.2.2 Renhe Pharmacy Business Overview
11.2.3 Renhe Pharmacy Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.2.4 Renhe Pharmacy Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Renhe Pharmacy Frozen Shoulder Treatment Drugs Sales by Product in 2024
11.2.6 Renhe Pharmacy Frozen Shoulder Treatment Drugs Sales by Application in 2024
11.2.7 Renhe Pharmacy Frozen Shoulder Treatment Drugs Sales by Geographic Area in 2024
11.2.8 Renhe Pharmacy Frozen Shoulder Treatment Drugs SWOT Analysis
11.2.9 Renhe Pharmacy Recent Developments
11.3 Sunflower Pharmaceutical
11.3.1 Sunflower Pharmaceutical Corporation Information
11.3.2 Sunflower Pharmaceutical Business Overview
11.3.3 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.3.4 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs Sales by Product in 2024
11.3.6 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs Sales by Application in 2024
11.3.7 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs Sales by Geographic Area in 2024
11.3.8 Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs SWOT Analysis
11.3.9 Sunflower Pharmaceutical Recent Developments
11.4 DR.ROTUS
11.4.1 DR.ROTUS Corporation Information
11.4.2 DR.ROTUS Business Overview
11.4.3 DR.ROTUS Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.4.4 DR.ROTUS Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 DR.ROTUS Frozen Shoulder Treatment Drugs Sales by Product in 2024
11.4.6 DR.ROTUS Frozen Shoulder Treatment Drugs Sales by Application in 2024
11.4.7 DR.ROTUS Frozen Shoulder Treatment Drugs Sales by Geographic Area in 2024
11.4.8 DR.ROTUS Frozen Shoulder Treatment Drugs SWOT Analysis
11.4.9 DR.ROTUS Recent Developments
11.5 Tongrentang
11.5.1 Tongrentang Corporation Information
11.5.2 Tongrentang Business Overview
11.5.3 Tongrentang Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.5.4 Tongrentang Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Tongrentang Frozen Shoulder Treatment Drugs Sales by Product in 2024
11.5.6 Tongrentang Frozen Shoulder Treatment Drugs Sales by Application in 2024
11.5.7 Tongrentang Frozen Shoulder Treatment Drugs Sales by Geographic Area in 2024
11.5.8 Tongrentang Frozen Shoulder Treatment Drugs SWOT Analysis
11.5.9 Tongrentang Recent Developments
11.6 Jiugang Pharmaceutical
11.6.1 Jiugang Pharmaceutical Corporation Information
11.6.2 Jiugang Pharmaceutical Business Overview
11.6.3 Jiugang Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.6.4 Jiugang Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Jiugang Pharmaceutical Recent Developments
11.7 Hisamitsu
11.7.1 Hisamitsu Corporation Information
11.7.2 Hisamitsu Business Overview
11.7.3 Hisamitsu Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.7.4 Hisamitsu Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hisamitsu Recent Developments
11.8 Kobayashi Pharmaceutical
11.8.1 Kobayashi Pharmaceutical Corporation Information
11.8.2 Kobayashi Pharmaceutical Business Overview
11.8.3 Kobayashi Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.8.4 Kobayashi Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Kobayashi Pharmaceutical Recent Developments
11.9 Haishi Hainuo Group
11.9.1 Haishi Hainuo Group Corporation Information
11.9.2 Haishi Hainuo Group Business Overview
11.9.3 Haishi Hainuo Group Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.9.4 Haishi Hainuo Group Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Haishi Hainuo Group Recent Developments
11.10 North China Pharmaceutical
11.10.1 North China Pharmaceutical Corporation Information
11.10.2 North China Pharmaceutical Business Overview
11.10.3 North China Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.10.4 North China Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 North China Pharmaceutical Recent Developments
11.11 Qizheng Tibetan Medicine
11.11.1 Qizheng Tibetan Medicine Corporation Information
11.11.2 Qizheng Tibetan Medicine Business Overview
11.11.3 Qizheng Tibetan Medicine Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.11.4 Qizheng Tibetan Medicine Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Qizheng Tibetan Medicine Recent Developments
11.12 Baiyunshan Pharmaceutical
11.12.1 Baiyunshan Pharmaceutical Corporation Information
11.12.2 Baiyunshan Pharmaceutical Business Overview
11.12.3 Baiyunshan Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.12.4 Baiyunshan Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Baiyunshan Pharmaceutical Recent Developments
11.13 Hengjian Pharmaceutical
11.13.1 Hengjian Pharmaceutical Corporation Information
11.13.2 Hengjian Pharmaceutical Business Overview
11.13.3 Hengjian Pharmaceutical Frozen Shoulder Treatment Drugs Product Models, Descriptions and Specifications
11.13.4 Hengjian Pharmaceutical Frozen Shoulder Treatment Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Hengjian Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Frozen Shoulder Treatment Drugs Industry Chain
12.2 Frozen Shoulder Treatment Drugs Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Frozen Shoulder Treatment Drugs Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Frozen Shoulder Treatment Drugs Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Frozen Shoulder Treatment Drugs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Frozen Shoulder Treatment Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Frozen Shoulder Treatment Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Frozen Shoulder Treatment Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Frozen Shoulder Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Frozen Shoulder Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Frozen Shoulder Treatment Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Frozen Shoulder Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 8. Global Frozen Shoulder Treatment Drugs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Frozen Shoulder Treatment Drugs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Frozen Shoulder Treatment Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global Frozen Shoulder Treatment Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Frozen Shoulder Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Frozen Shoulder Treatment Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frozen Shoulder Treatment Drugs as of 2024)
Table 16. Global Frozen Shoulder Treatment Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Frozen Shoulder Treatment Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Frozen Shoulder Treatment Drugs Manufacturing Base and Headquarters
Table 19. Global Frozen Shoulder Treatment Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Frozen Shoulder Treatment Drugs Sales by Type (2020-2025) & (K Units)
Table 23. Global Frozen Shoulder Treatment Drugs Sales by Type (2026-2031) & (K Units)
Table 24. Global Frozen Shoulder Treatment Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Frozen Shoulder Treatment Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Frozen Shoulder Treatment Drugs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Frozen Shoulder Treatment Drugs Sales by Application (2020-2025) & (K Units)
Table 29. Global Frozen Shoulder Treatment Drugs Sales by Application (2026-2031) & (K Units)
Table 30. Frozen Shoulder Treatment Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Frozen Shoulder Treatment Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Frozen Shoulder Treatment Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Frozen Shoulder Treatment Drugs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Frozen Shoulder Treatment Drugs Growth Accelerators and Market Barriers
Table 37. North America Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Frozen Shoulder Treatment Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Frozen Shoulder Treatment Drugs Growth Accelerators and Market Barriers
Table 40. Europe Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Frozen Shoulder Treatment Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Frozen Shoulder Treatment Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Frozen Shoulder Treatment Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Frozen Shoulder Treatment Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Frozen Shoulder Treatment Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Frozen Shoulder Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Yunnan Baiyao Corporation Information
Table 51. Yunnan Baiyao Description and Major Businesses
Table 52. Yunnan Baiyao Product Models, Descriptions and Specifications
Table 53. Yunnan Baiyao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Yunnan Baiyao Sales Value Proportion by Product in 2024
Table 55. Yunnan Baiyao Sales Value Proportion by Application in 2024
Table 56. Yunnan Baiyao Sales Value Proportion by Geographic Area in 2024
Table 57. Yunnan Baiyao Frozen Shoulder Treatment Drugs SWOT Analysis
Table 58. Yunnan Baiyao Recent Developments
Table 59. Renhe Pharmacy Corporation Information
Table 60. Renhe Pharmacy Description and Major Businesses
Table 61. Renhe Pharmacy Product Models, Descriptions and Specifications
Table 62. Renhe Pharmacy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Renhe Pharmacy Sales Value Proportion by Product in 2024
Table 64. Renhe Pharmacy Sales Value Proportion by Application in 2024
Table 65. Renhe Pharmacy Sales Value Proportion by Geographic Area in 2024
Table 66. Renhe Pharmacy Frozen Shoulder Treatment Drugs SWOT Analysis
Table 67. Renhe Pharmacy Recent Developments
Table 68. Sunflower Pharmaceutical Corporation Information
Table 69. Sunflower Pharmaceutical Description and Major Businesses
Table 70. Sunflower Pharmaceutical Product Models, Descriptions and Specifications
Table 71. Sunflower Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Sunflower Pharmaceutical Sales Value Proportion by Product in 2024
Table 73. Sunflower Pharmaceutical Sales Value Proportion by Application in 2024
Table 74. Sunflower Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 75. Sunflower Pharmaceutical Frozen Shoulder Treatment Drugs SWOT Analysis
Table 76. Sunflower Pharmaceutical Recent Developments
Table 77. DR.ROTUS Corporation Information
Table 78. DR.ROTUS Description and Major Businesses
Table 79. DR.ROTUS Product Models, Descriptions and Specifications
Table 80. DR.ROTUS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. DR.ROTUS Sales Value Proportion by Product in 2024
Table 82. DR.ROTUS Sales Value Proportion by Application in 2024
Table 83. DR.ROTUS Sales Value Proportion by Geographic Area in 2024
Table 84. DR.ROTUS Frozen Shoulder Treatment Drugs SWOT Analysis
Table 85. DR.ROTUS Recent Developments
Table 86. Tongrentang Corporation Information
Table 87. Tongrentang Description and Major Businesses
Table 88. Tongrentang Product Models, Descriptions and Specifications
Table 89. Tongrentang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Tongrentang Sales Value Proportion by Product in 2024
Table 91. Tongrentang Sales Value Proportion by Application in 2024
Table 92. Tongrentang Sales Value Proportion by Geographic Area in 2024
Table 93. Tongrentang Frozen Shoulder Treatment Drugs SWOT Analysis
Table 94. Tongrentang Recent Developments
Table 95. Jiugang Pharmaceutical Corporation Information
Table 96. Jiugang Pharmaceutical Description and Major Businesses
Table 97. Jiugang Pharmaceutical Product Models, Descriptions and Specifications
Table 98. Jiugang Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Jiugang Pharmaceutical Recent Developments
Table 100. Hisamitsu Corporation Information
Table 101. Hisamitsu Description and Major Businesses
Table 102. Hisamitsu Product Models, Descriptions and Specifications
Table 103. Hisamitsu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Hisamitsu Recent Developments
Table 105. Kobayashi Pharmaceutical Corporation Information
Table 106. Kobayashi Pharmaceutical Description and Major Businesses
Table 107. Kobayashi Pharmaceutical Product Models, Descriptions and Specifications
Table 108. Kobayashi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Kobayashi Pharmaceutical Recent Developments
Table 110. Haishi Hainuo Group Corporation Information
Table 111. Haishi Hainuo Group Description and Major Businesses
Table 112. Haishi Hainuo Group Product Models, Descriptions and Specifications
Table 113. Haishi Hainuo Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Haishi Hainuo Group Recent Developments
Table 115. North China Pharmaceutical Corporation Information
Table 116. North China Pharmaceutical Description and Major Businesses
Table 117. North China Pharmaceutical Product Models, Descriptions and Specifications
Table 118. North China Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. North China Pharmaceutical Recent Developments
Table 120. Qizheng Tibetan Medicine Corporation Information
Table 121. Qizheng Tibetan Medicine Description and Major Businesses
Table 122. Qizheng Tibetan Medicine Product Models, Descriptions and Specifications
Table 123. Qizheng Tibetan Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Qizheng Tibetan Medicine Recent Developments
Table 125. Baiyunshan Pharmaceutical Corporation Information
Table 126. Baiyunshan Pharmaceutical Description and Major Businesses
Table 127. Baiyunshan Pharmaceutical Product Models, Descriptions and Specifications
Table 128. Baiyunshan Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Baiyunshan Pharmaceutical Recent Developments
Table 130. Hengjian Pharmaceutical Corporation Information
Table 131. Hengjian Pharmaceutical Description and Major Businesses
Table 132. Hengjian Pharmaceutical Product Models, Descriptions and Specifications
Table 133. Hengjian Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Hengjian Pharmaceutical Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources


List of Figures
Figure 1. Frozen Shoulder Treatment Drugs Product Picture
Figure 2. Global Frozen Shoulder Treatment Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. External Use Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Frozen Shoulder Treatment Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital Clinic
Figure 7. Pharmacy
Figure 8. Online Shopping Mall
Figure 9. Frozen Shoulder Treatment Drugs Report Years Considered
Figure 10. Global Frozen Shoulder Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 12. Global Frozen Shoulder Treatment Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Frozen Shoulder Treatment Drugs Revenue Market Share by Region (2020-2031)
Figure 14. Global Frozen Shoulder Treatment Drugs Sales (2020-2031) & (K Units)
Figure 15. Global Frozen Shoulder Treatment Drugs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Frozen Shoulder Treatment Drugs Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Frozen Shoulder Treatment Drugs Sales Volume Market Share in 2024
Figure 18. Global Frozen Shoulder Treatment Drugs Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. External Use Revenue Market Share by Manufacturer in 2024
Figure 21. Oral Revenue Market Share by Manufacturer in 2024
Figure 22. Global Frozen Shoulder Treatment Drugs Sales Market Share by Type (2020-2031)
Figure 23. Global Frozen Shoulder Treatment Drugs Revenue Market Share by Type (2020-2031)
Figure 24. Global Frozen Shoulder Treatment Drugs Sales Market Share by Application (2020-2031)
Figure 25. Global Frozen Shoulder Treatment Drugs Revenue Market Share by Application (2020-2031)
Figure 26. North America Frozen Shoulder Treatment Drugs Sales YoY (2020-2031) & (K Units)
Figure 27. North America Frozen Shoulder Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) in 2024
Figure 29. North America Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Frozen Shoulder Treatment Drugs Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Frozen Shoulder Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) in 2024
Figure 39. Europe Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 44. France Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Frozen Shoulder Treatment Drugs Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Frozen Shoulder Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 59. India Frozen Shoulder Treatment Drugs Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Frozen Shoulder Treatment Drugs Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Frozen Shoulder Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Frozen Shoulder Treatment Drugs Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Frozen Shoulder Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Frozen Shoulder Treatment Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Frozen Shoulder Treatment Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Frozen Shoulder Treatment Drugs Revenue (2020-2025) & (US$ Million)
Figure 80. Frozen Shoulder Treatment Drugs Industry Chain Mapping
Figure 81. Regional Frozen Shoulder Treatment Drugs Manufacturing Base Distribution (%)
Figure 82. Global Frozen Shoulder Treatment Drugs Production Market Share by Region (2020-2031)
Figure 83. Frozen Shoulder Treatment Drugs Production Process
Figure 84. Regional Frozen Shoulder Treatment Drugs Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies